Study of a new drug for acute schizophrenia symptoms
Part of Mental health clinical trials.
This trial tests an experimental medicine, LTX-001, for people with schizophrenia who are currently having a sudden worsening of symptoms. It aims to see if the drug can help reduce these acute symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of schizophrenia and are currently experiencing a sudden worsening of your symptoms that started less than 2 months ago.
- You are not currently on antipsychotic medication, or you are willing to stop taking certain psychiatric medicines during the study.
- You have a body weight over 110 pounds (50 kg) and a BMI between 17.5 and 38.
- You do not have any other major mental health diagnosis besides schizophrenia.
- You do not have a history of substance abuse (drugs or alcohol) in the past year, and you have not used recreational drugs in the last 3 months.
- If you are sexually active, you must agree to use effective birth control throughout the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug, ML-007C-MA, for adults with schizophrenia who may benefit from ongoing treatment. It aims to see how safe and effective the drug is over a longer period.
This trial tests an investigational medicine called NBI-1117568 in adults with schizophrenia who are currently having a relapse or worsening of symptoms and need to stay in the hospital. The goal is to see if the medicine is safe and effective.
This trial tests a new medication called LB-102 for people with acute (sudden worsening of) schizophrenia. It aims to see if the drug helps reduce symptoms like hallucinations or disorganized thinking.
This study is testing how safe and tolerable an investigational medication is over the long term (52 weeks) when added to your current antipsychotic treatment. It's for people with schizophrenia whose symptoms are stable, and it aims to see if the new medication can help without causing serious side effects.
This study tests a new medication (LY03020) for people with schizophrenia who are currently having a flare-up of symptoms severe enough to require hospital care. The goal is to see if the drug safely reduces psychotic symptoms like hallucinations and delusions.
This trial tests a new drug, GXV813, to see if it helps reduce symptoms in people with schizophrenia who are currently hospitalized due to a sudden worsening of their condition. It compares the drug's safety and effect against a placebo over several weeks.
Hear when a new Schizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.